Bofei Wang

577 total citations
24 papers, 151 citations indexed

About

Bofei Wang is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Bofei Wang has authored 24 papers receiving a total of 151 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 10 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Bofei Wang's work include Acute Myeloid Leukemia Research (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Immunotherapy and Immune Responses (5 papers). Bofei Wang is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Immunotherapy and Immune Responses (5 papers). Bofei Wang collaborates with scholars based in United States, China and Malaysia. Bofei Wang's co-authors include Cuipeng Qiu, Jianying Zhang, Jing Hang, Wanqiong Yuan, Weiling Li, Jianxiang Shi, Peng Wang, Hua Ye, Liping Dai and Xiao Wang and has published in prestigious journals such as Blood, ACS Nano and Cancer.

In The Last Decade

Bofei Wang

23 papers receiving 150 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bofei Wang United States 8 89 43 38 32 26 24 151
Omar Saavedra Spain 9 86 1.0× 14 0.3× 36 0.9× 11 0.3× 30 1.2× 22 167
Izabela Todorovski Australia 5 126 1.4× 30 0.7× 62 1.6× 8 0.3× 28 1.1× 10 199
Phuong M. Le United States 5 77 0.9× 14 0.3× 45 1.2× 16 0.5× 51 2.0× 14 146
Russell Wall United States 3 187 2.1× 67 1.6× 38 1.0× 40 1.3× 30 1.2× 6 239
Shenglai Li United States 4 117 1.3× 52 1.2× 16 0.4× 7 0.2× 31 1.2× 5 171
Vera Labitzky Germany 9 77 0.9× 37 0.9× 19 0.5× 17 0.5× 7 0.3× 13 141
Laura Wiehle Germany 5 240 2.7× 23 0.5× 19 0.5× 26 0.8× 9 0.3× 7 279
Ceyda Durmaz United States 3 109 1.2× 25 0.6× 39 1.0× 6 0.2× 59 2.3× 5 170
Peter‐Martin Bruch Germany 7 71 0.8× 17 0.4× 21 0.6× 9 0.3× 6 0.2× 15 126
Chiara Pastori United States 5 228 2.6× 166 3.9× 13 0.3× 11 0.3× 15 0.6× 14 267

Countries citing papers authored by Bofei Wang

Since Specialization
Citations

This map shows the geographic impact of Bofei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bofei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bofei Wang more than expected).

Fields of papers citing papers by Bofei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bofei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bofei Wang. The network helps show where Bofei Wang may publish in the future.

Co-authorship network of co-authors of Bofei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Bofei Wang. A scholar is included among the top collaborators of Bofei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bofei Wang. Bofei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bataller, Álex, Bofei Wang, Courtney D. DiNardo, et al.. (2025). Mutation dynamics from diagnosis to relapse in acute myeloid leukemia with chromosomal 7 deletions. Leukemia & lymphoma. 66(7). 1221–1233.
2.
Wang, Bofei, Patrick K. Reville, & Hussein A. Abbas. (2025). Therapeutic hurdles in acute myeloid leukemia: Leukemic stem cells, inflammation and immune dysfunction. Current Opinion in Pharmacology. 82. 102526–102526. 1 indexed citations
3.
Khouri, Maria, Bofei Wang, Lloyd Hutchinson, et al.. (2025). Characteristics and clinical outcomes of patients with myeloid malignancies and cohesin mutations. Cancer. 131(8). e35846–e35846. 1 indexed citations
4.
Wang, Bofei, et al.. (2024). Fuzzy logic optimized threshold-based energy management strategy for fuel cell hybrid E-bike. International Journal of Hydrogen Energy. 63. 123–132. 8 indexed citations
5.
Radpour, Ramin, Cédric Simillion, Bofei Wang, et al.. (2024). IL-9 secreted by leukemia stem cells induces Th1-skewed CD4+ T cells, which promote their expansion. Blood. 144(8). 888–903. 7 indexed citations
6.
Wang, Bofei, Fatima Zahra Jelloul, Sean Mackay, et al.. (2024). Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy. Cancer Research Communications. 4(3). 671–681. 5 indexed citations
7.
Wang, Yi, Chaoyi Deng, Lijuan Zhao, et al.. (2024). Time-Dependent and Coating Modulation of Tomato Response upon Sulfur Nanoparticle Internalization and Assimilation: An Orthogonal Mechanistic Investigation. ACS Nano. 18(18). 11813–11827. 7 indexed citations
8.
Wang, Bofei, Tianhao Li, Naval Daver, et al.. (2024). Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia. Journal for ImmunoTherapy of Cancer. 12(2). e008318–e008318. 5 indexed citations
9.
Vadakekolathu, Jayakumar, Sarah Skuli, David J. Boocock, et al.. (2024). Multi-Omic Analyses of TP53-Mutated Acute Myeloid Leukemia Identify Prognostic Metabolic Signatures. Blood. 144(Supplement 1). 2911–2911. 2 indexed citations
10.
Wang, Bofei, et al.. (2024). Opioid Prescribing and Outcomes in Patients With Sickle Cell Disease Post–2016 CDC Guideline. JAMA Internal Medicine. 184(5). 510–510. 5 indexed citations
11.
Fan, Huihui, Feng Wang, Andy G.X. Zeng, et al.. (2023). Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance. Communications Biology. 6(1). 765–765. 11 indexed citations
12.
13.
Qiu, Cuipeng, et al.. (2023). Autoantibodies to PAX5, PTCH1, and GNA11 as Serological Biomarkers in the Detection of Hepatocellular Carcinoma in Hispanic Americans. International Journal of Molecular Sciences. 24(4). 3721–3721. 2 indexed citations
14.
Wang, Keyan, Cuipeng Qiu, Miao Li, et al.. (2023). Association of elevated autoantibody to high expression of GNAS in hepatocellular carcinoma. Heliyon. 9(12). e22627–e22627. 2 indexed citations
15.
Wang, Bofei, Patrick K. Reville, Fatima Zahra Jelloul, et al.. (2023). Single-Cell Characterization of TP53-Mutated AML Patients Treated with Frontline Azacitidine, Venetoclax, and Magrolimab Reveals Mechanisms of Response and Resistance. Blood. 142(Supplement 1). 64–64. 2 indexed citations
16.
Wang, Xiao, Keyan Wang, Cuipeng Qiu, et al.. (2022). Autoantibody to GNAS in Early Detection of Hepatocellular Carcinoma: A Large-Scale Sample Study Combined with Verification in Serial Sera from HCC Patients. Biomedicines. 10(1). 97–97. 6 indexed citations
17.
18.
Qiu, Cuipeng, Bofei Wang, Xiaojun Zhang, et al.. (2022). Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma. Cells. 11(20). 3227–3227. 6 indexed citations
19.
Qiu, Cuipeng, Bofei Wang, Jianxiang Shi, et al.. (2021). Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer. Frontiers in Immunology. 12. 698312–698312. 16 indexed citations
20.
Wang, Bofei, Jing Hang, Weiling Li, & Wanqiong Yuan. (2020). <p>Knockdown of LncRNA DLEU2 Inhibits Cervical Cancer Progression via Targeting miR-128-3p</p>. OncoTargets and Therapy. Volume 13. 10173–10184. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Omar Saavedra Breakdown of academic impact, for papers by Izabela Todorovski Breakdown of academic impact, for papers by Phuong M. Le Breakdown of academic impact, for papers by Russell Wall Breakdown of academic impact, for papers by Shenglai Li Breakdown of academic impact, for papers by Vera Labitzky Breakdown of academic impact, for papers by Laura Wiehle Breakdown of academic impact, for papers by Ceyda Durmaz Breakdown of academic impact, for papers by Peter‐Martin Bruch Breakdown of academic impact, for papers by Chiara Pastori
Rankless by CCL
2026